RZRaheel Zubair

Raheel Zubair

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Raheel Zubair has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • An in vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics*

    by G. Vellaichamy, I. Kohli, R. Zubair, C. Yin, T. Braunberger, A.F. Nahhas, C. Nicholson, T.F. Mohammad, P. Isedeh, A.B. Lyons, et al.

    Background Post-inflammatory hyperpigmentation (PIH) is a common, acquired pigmentary disorder of the skin associated with significant quality of life impairment, especially in skin of color individuals. Current treatment for PIH is limited, largely due to a poor understanding of disease pathogenesis and the lack of a representative disease model. Objectives This study is intended to further develop, update, and validate our previously designed in vivo model of acne-induced PIH/post-inflammatory erythema (PIE) using different concentrations of trichloroacetic acid (TCA), a medium-depth chemical peel. Methods 29 patients with skin types I-VI and clinician-confirmed presence of two or more truncal acne pustules and PIH/PIE were included. On the basis of IGA, CPP, colorimetry, and skindex, we (2) experimentally determine an optimum TCA-concentration and assess our model’s ability to exhibit a dose-response relationship between degree of inciting insult and severity of resulting pigmentation. We also (3) perform differential microRNA profiling and pathway analysis to explore the potential of microRNAs as molecular adjuncts to our model. Results Application of 30% TCA produced lesions indistinguishable from acne-induced PIH and PIE lesions on the basis of colorimetry data without causing epidermal necrosis. Application of progressively increasing TCA doses from 20%-30% resulted in concentration-dependent increases in CPP, IGA, and colorimetry scores at all time points during the study. miRNA-31 and miRNA-23b may play a role in PIH pathogenesis, though further validation is required. Conclusions Our TCA-based in vivo model, using TCA concentrations between 20-30% with an optimum of 30%, enables the quantitative assessment of the pigmentary response to varying degrees of cutaneous inflammation in a fashion that mirrors natural acne-induced PIH and PIE.


  • Assessment of inter‐rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography

    by A. B. Lyons, S. Narla, I. Kohli, R. Zubair, A. F. Nahhas, T. L. Braunberger, M. K. Joseph, C. L. Nicholson, G. Jacobsen, I. H. Hamzavi

    Background Hidradenitis suppurativa (HS) staging and severity is typically based upon physical examination findings which can result in misclassification of severity based on subclinical disease activity and significant variation between healthcare providers. Ultrasound (US) is an objective tool to help evaluate subclinical disease and more accurately classify severity of disease. The objective of this study was to evaluate inter-rater reliability in HS disease severity assessment using clinical and US techniques. Methods Twenty subjects underwent clinical evaluation of HS using clinical outcome measures including Hurley, Sartorius, HS Physician Global Assessment (HS-PGA), and Hidradenitis Suppurativa Clinical Response (HiSCR) independently by two physicians. US was subsequently performed, and clinical assessments were repeated. Intra-class correlation coefficients (ICC) were obtained to evaluate inter-rater agreement of each outcome measure before and after US. Results Pre- to post-US improvement in ICC was seen with the Sartorius, HiSCR nodule and abscess count, and HiSCR draining fistula count. The scores went from having “good” rater agreement for Sartorius and HiSCR nodule and abscess count and “poor” rater agreement for HiSCR draining fistula count to “excellent” rater agreement amongst these scores. Conclusions US improved inter-rater agreement and should be used in conjunction with physical examination findings to evaluate disease severity to ensure uniform staging.